iBloodPressure Reduces Hypertension in 71 Percent of Patients

iBloodPressure monitoring device and data platform for hypertension by Smart Meter, data showed that 71 percent of the patients with elevated levels of hypertension saw a reduction after only 3-½ months of using the iBloodPressure.

The iBloodPressure is a cellular-connected blood pressure monitoring system that automatically transmit blood pressure data to a remote patient monitoring system or electronic health record (EHR) system (including PointClickCare).

This provides more accurate tracking of blood pressure data and saves staff time in healthcare facilities by not having to manually write down or input results.

During the 14 weeks that results were noted, 88 percent of the participants who had the highest levels of blood pressure readings (Stage II) saw a reduction in blood pressure levels and 75 percent of them stepped down one stage or more.

Even the participants who started at a lower level of high blood pressure (Stage I), saw improvements, with 71 percent seeing a reduction in their results and 50 percent stepping down one stage or more.

“Using the cellular-connected iBloodPressure to track trends in a patient’s blood pressure is easy in any setting and provides greater access to the data for both the provider and the patient,” said Casey Pittock, Smart Meter CEO.

He added, “This ease-of-use improves patient engagement so that the patient will utilize the device as prescribed by their provider, which leads to better health outcomes.”

Smart Meter’s iBloodPressure is being utilized in many healthcare settings, including remote patient monitoring programs by physicians, long-term care facilities, and home care providers.

“We have seen great results with iBloodPressure from the many physician practices our Remote Patient Monitoring Platform and services support”, said Samson Magid, CEO of HealthSnap. “The health care professionals we serve appreciate the simplicity and reliability of this cellular blood pressure device from Smart Meter.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version